EVIDENT and Ultivue collaborate to advance multiplex slide imaging and spatial analysis in translational research

AI nuclear energy background, future innovation of disruptive technology

Evident Corporation, a premier manufacturer of life science imaging systems, and Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, announced a collaborative agreement to promote whole slide imaging using multiplexed immunofluorescence (mIF) assays to advance translational research in the Americas.

Shuffle play over 100 million songs and podcasts for free with Amazon Music Prime

Previous article

Access over 200 hours of IT fundamentals with this discounted course bundle

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News